Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$0.03.

  • Lifecore Biomedical's EPS (Weighted Average and Diluted) rose 84.21% to -$0.03 in Q2 2025 from the same period last year, while for May 2025 it was -$1.28, marking a year-over-year decrease of 709.52%. This contributed to the annual value of -$1.27 for FY2025, which is 484.85% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's EPS (Weighted Average and Diluted) is -$0.03, which was up 93.62% from -$0.47 recorded in Q1 2025.
  • Lifecore Biomedical's 5-year EPS (Weighted Average and Diluted) high stood at $0.42 for Q1 2024, and its period low was -$1.88 during Q2 2022.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.36, with a median of -$0.33 in 2024.
  • In the last 5 years, Lifecore Biomedical's EPS (Weighted Average and Diluted) crashed by 6,166.67% in 2022 and then surged by 190.70% in 2023.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's EPS (Weighted Average and Diluted) stood at -$1.31 in 2021, then skyrocketed by 67.18% to -$0.43 in 2022, then spiked by 190.70% to $0.39 in 2023, then crashed by 164.10% to -$0.25 in 2024, then soared by 84.21% to -$0.03 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.03 for Q2 2025, versus -$0.47 for Q1 2025 and -$0.25 for Q4 2024.